Zalcitabine. (Record no. 8096741)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01236 a2200373 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513061209.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199305s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1060-0280 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1177/106002809302700416 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Shelton, M J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19930521 |
245 00 - TITLE STATEMENT | |
Title | Zalcitabine. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Annals of pharmacotherapy |
Date of publication, distribution, etc. | Apr 1993 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 480-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CD4-Positive T-Lymphocytes |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Child, Preschool |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase I as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase II as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infant |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Zalcitabine |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Zidovudine |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | O'Donnell, A M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Morse, G D |
773 0# - HOST ITEM ENTRY | |
Title | The Annals of pharmacotherapy |
Related parts | vol. 27 |
-- | no. 4 |
-- | p. 480-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1177/106002809302700416">https://doi.org/10.1177/106002809302700416</a> |
Public note | Available from publisher's website |
No items available.